Stay updated on Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.3 to v3.5.4, indicating a new revision of the study record metadata.
    Difference
    0.1%
    Check dated 2026-05-15T15:19:35.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    The page’s display footer was updated to reflect a newer ClinicalTrials.gov site revision (v3.5.3) instead of the previous (v3.5.2). This is a versioning/maintenance update rather than a change to the underlying study record details.
    Difference
    0.1%
    Check dated 2026-04-24T06:01:00.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:39:48.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Page revision updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T06:25:16.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Revision label updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:36:37.000Z thumbnail image
  9. Check
    111 days ago
    Change Detected
    Summary
    Site revision updated to Revision: v3.4.2, and the previous government funding status notice (v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T14:35:22.000Z thumbnail image

Stay in the know with updates to Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page.